Systemic Immune-Inflammatory Index as a Predictor of Lymph Node Metastasis in Endometrial Cancer
HuiFang Lei,ShuXia Xu,XiaoDan Mao,XiaoYing Chen,YaoJia Chen,XiaoQi Sun,PengMing Sun
DOI: https://doi.org/10.2147/JIR.S345790
IF: 4.5
2021-12-21
Journal of Inflammation Research
Abstract:HuiFang Lei, 1, 2, &ast ShuXia Xu, 3, &ast XiaoDan Mao, 1, 2 XiaoYing Chen, 4 YaoJia Chen, 1, 2 XiaoQi Sun, 4 PengMing Sun 1, 2, 4 1 Laboratory of Gynecologic Oncology, Department of Gynecology, Fujian Provincial Maternity and Children's Hospital, Affiliated Hospital of Fujian Medical University, Fuzhou, People's Republic of China; 2 Fujian Key Laboratory of Women and Children's Critical Diseases Research, Fujian Provincial Maternity and Children's Hospital, Affiliated Hospital of Fujian Medical University, Fuzhou, People's Republic of China; 3 Department of Pathology, Fujian Provincial Maternity and Children's Hospital, Affiliated Hospital of Fujian Medical University, Fuzhou, People's Republic of China; 4 Department of Gynecology, Fujian Provincial Maternity and Children's Hospital, Affiliated Hospital of Fujian Medical University, Fuzhou, People's Republic of China &astThese authors contributed equally to this work Correspondence: XiaoQi Sun; PengMing Sun Laboratory of Gynecologic Oncology, Fujian Provincial Maternity and Children's Hospital, Affiliated Hospital of Fujian Medical University, No. 18 Daoshan Road, Fuzhou, 350001, Fujian, People's Republic of China Email ; Purpose: This study assessed the predictive value of the preoperative systemic immune-inflammatory index (SII) for lymph node metastasis (LNM) in endometrial cancer (EC) patients. Methods: We retrospectively included 392 EC patients between January 2013 and January 2019. Data on clinical indicators including age, body mass index (BMI), menopause, serum inflammatory immune index, serum tumor markers, history of diabetes and hypertension, stage, histological type, and myometrial invasion (MI) were collected. The association between clinical indicators and LNM was evaluated. Results: The results indicated that neutrophil (NE), monocyte (MO) counts, SII, cancer antigen 125 (CA125), cancer antigen 153 (CA153), cancer antigen 199 (CA199), and the expression of estrogen receptor (ER) and Ki67 were higher in EC patients with LNM than in those without LNM (P< 0.05). Lymph vascular space invasion (LVSI) was also associated with LNM (P< 0.05). Consequently, the SII, CA125, CA153 and LVSI were found to be independent risk factors for LNM, and a nomogram including these indicators was performed. The ROC curve analysis showed that compared with a single index, the combination of the SII, CA125, CA153 and LVSI significantly improved the efficiency of diagnosing LNM in EC patients (AUC=0.865, P < 0.001). Moreover, the SII was significantly associated with age, menopause, and FIGO stage (P < 0.05). Further logistic regression analysis suggested that elevated serum SII was an independent risk factor for MI and progression to a higher pathological grade in young premenopausal EC patients. In addition, elevated SII was an independent risk factor for advanced EC progression in age ≥ 55 or postmenopausal EC patients. Conclusion: An elevated SII is an independent risk factor for LNM in patients with EC. In addition, the SII can be used as a predictor of MI and higher pathological grade in young premenopausal EC patients. Keywords: systemic immune-inflammatory index, neutrophil, platelet, lymphocyte count, lymph node metastasis, endometrial cancer Endometrial cancer (EC) is one of the most common malignant tumors of the female reproductive tract, with a lymph node metastasis (LNM) rate ranging from 10.5% to 14.9%. 1–3 LNM is an important factor influencing the poor prognosis of EC patients, which not only affects the pathological stage of surgery but also may lead to serious consequences such as recurrence and distant metastasis, thus reducing the long-term survival rate of patients. 3,4 Surgery is the preferred treatment for EC, and the basic surgical methods include cytological examination with retention of peritoneal fluid, laparoscopic extrafascial hysterectomy, bilateral adnexectomy, and abdominal aorta and pelvic lymph node dissection. 4 However, the need for para-aortic and pelvic lymph node dissection in patients with low-risk and stage IA EC remains controversial. Some scholars believe that standardized lymph node dissection not only has auxiliary value in diagnosing LNM in patients with EC but also provides guidance for standardized postoperative treatment, which can reduce postoperative pelvic recurrence. 5,6 However, some scholars believe that lymph node dissection does not improve the survival rate and tumor-free survival of patients but does cause lower limb pain, urinary fistula, bladder fistula and other -Abstract Truncated-
immunology